(60 Tests)

The result from NTproBNP assay aids in the diagnosis and assessment of severity of congestive heart failure (CHF) and risk stratification in patients with acute coronary syndrome.

PATHFAST determines the quantity of NTproBNP from both whole blood and plasma samples, providing results within minutes, and facilitating critical care decisions for patients with acute myocardial infarction, deep vein thrombosis, pulmonary embolism and congestive heart failure.

FDA Cleared for Moderate Complexity Labs - Not CLIAwaived.


Assay range:  15 – 30,000 pg/mL

Total imprecision at 101 pg/mL, near the clinical cutoff of 125 pg/mL:  4.7%

Total imprecision at 425 pg/mL, near the clinical cutoff of 450 pg/mL:  3.4%

Correlation between lithium heparin plasma and whole blood:  R = 0.991

Correlation between lithium heparin plasma and EDTA plasma:  R = 1.000

Correlation between EDTA plasma and EDTA whole blood:  R = 0.996


*Data above listed on the product indication for use (IFU)

© 2020 Cliawaived, Inc. All Rights Reserved. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.